1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Bruker Corporation

Bruker Corporation

BRKR
Bruker CorporationUS flagNASDAQ Global Select
53.43
USD
-1.00
- -
8.13BMarket Cap
Bruker Corporation
BRKR
(NASDAQ Global Select)

Recent

price

53.43

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
7.94
9.99
10.79
11.05
10.78
9.65
9.98
11.17
12.14
13.35
12.96
15.97
17.03
20.25
22.59
22.64
23.01
Revenue per Share
0.58
0.56
0.47
0.48
0.34
0.6
0.95
0.5
1.15
1.27
1.03
1.83
2
2.92
0.76
-0.15
-0.7
Basic EPS, GAAP
0.76
0.16
0.36
0.57
0.48
1.16
0.58
0.7
1.22
0.9
1.53
1.26
0.98
1.66
0.91
0.09
0.62
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
0.16
0.16
0.16
0.16
0.16
0.16
0.2
0.2
0.2
0.22
0.36
Dividend per Share
3.18
3.75
4.24
5.05
4.54
4.39
4.29
4.65
5.73
5.88
6.32
7.1
7.58
9.49
11.74
16.15
15.63
Book Value per Share
1.76
2.32
2.84
3.66
3.29
3.15
3.04
3.04
2.57
2.47
2.71
3.44
2.62
3.2
-4.21
0.06
0.55
Tangible Book Value per Share
164
165
166
166
168
168
161
158
156
155
153
151
149
146
149
152
152
Basic Weighted Avg Shares
1,305
1,652
1,791
1,839
1,809
1,624
1,611
1,766
1,896
2,073
1,988
2,418
2,531
2,964
3,366
3,436
3,500
Sales/Revenue/Turnover
12.38
9.95
10.19
9.28
7.46
9.86
12.88
13.53
14.63
14.73
13.45
17.64
18.27
16.5
11.26
6.87
7.6
Operating Margin (%)
36
53
59
61
60
53
54
64
65
76
80
89
89
115
184
220
230
Depreciation Expense
95
92
78
80
57
102
154
79
180
197
158
277
297
427
113
-9
-71
Net Income, GAAP
35.51
35.4
43.46
34.35
41.16
18.05
13.01
59.4
26.03
29.39
28.52
28.71
28.12
21.63
44.18
133.18
66.84
Effective Tax Rate (%)
7.31
5.59
4.33
4.35
3.13
6.26
9.53
4.45
9.48
9.51
7.94
11.46
11.72
14.41
3.36
-0.25
-2.03
Profit Margin (%)
220
438
628
783
784
677
751
834
705
1,151
1,133
1,533
1,199
962
772
933
1,020
Working Capital
87
219
336
354
354
265
392
416
323
860
889
1,264
1,235
1,235
2,181
1,991
1,815
LT Debt
527
625
710
850
772
733
693
734
928
938
974
1,085
1,132
1,413
1,815
2,510
2,436
Total Equity
14.23
11.28
9.85
9.56
6.6
11.88
16.72
8.4
16.32
13.43
9.83
13.32
13.12
14.08
5.93
-1.77
- -
Return on Invested Capital (%)
14.1
10.85
8.6
7.74
5.29
10.25
15.61
7.38
15.53
13.45
8.88
13
12.55
16.89
4.06
-0.67
2.37
Return on Capital (%)
20.26
16.11
11.67
10.32
7.03
13.62
21.75
11.13
22.16
21.87
16.9
27.28
27.16
34.3
7.16
-1.06
-5.11
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
52
8
10
LT Borrowings
1,852
1,663
1,815
LT Finance Leases
139
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
152
152
152
Market Capitalization
7,167
5,498
9,169

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,212
2,104
2,225
Cash, Cash Equivalents & STI
299
133
222
Accounts Receivable, Net
545
543
546
Inventories
1,095
1,122
1,120
Total Current Liabilities
1,279
1,355
1,205
Payables & Accruals
441
269
200
ST Debt
52
8
10
Deferred Revenue
441
480
445

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.91%
21.45%
38.29%
Free Cash Flow
-2.97%
-21.82%
-89.78%
Net Income, GAAP
6.63%
-10.89%
-107.6%
Sales/Revenue/Turnover
8.05%
11.82%
2.08%
Total Cash Common Dividend
- -
-2.84%
-37.09%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
722
801
864
980
3,366
2025
801
797
860
977
3,436
2026
823
838
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.35
0.05
0.27
0.09
0.76
2025
0.11
0.05
-0.41
0.1
-0.15
2026
0.02
-0.41
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.05
0.05
0.05
0.2
2025
0.05
0.05
- -
0.12
0.22
2026
0.12
0.12
- -
- -
- -
Similar Companies
Suzhou Basecare Medical Corporation Limited (2170.HK)
Arcoma AB (ARCOMA.ST)
Eurobio Scientific S.A. (ALERS.PA)
Cardiovascular Systems, Inc. (CSII)
CapsoVision, Inc. (CV)
Smith & Nephew plc (SNNUF)
Business
Bruker Corporation (Nasdaq: BRKR) develops, manufactures, and distributes high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at molecular, cellular, and microscopic levels. The company offers a broad portfolio of products including nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) spectrometers; mass spectrometry systems; X-ray diffraction, scattering, and microscope analyzers; infrared, near-infrared, and Raman spectroscopy instruments; fluorescence and electron microscopy solutions; preclinical imaging systems; elemental analyzers; surface plasmon resonance systems; microbiology and clinical diagnostic tools such as ClinMASS and ClinDART kits; CBRNE detectors; semiconductor metrology equipment; and laboratory automation, data management, and test & measurement solutions. These products support applications in life science molecular research, pharmaceuticals, biotechnology, materials science, microscopy and nanoanalysis, industrial quality control, preclinical imaging, clinical phenomics and proteomics, and clinical microbiology. Founded in 1960 and headquartered in Billerica, Massachusetts, Bruker operates globally with over 11,000 employees across more than 90 locations on all continents, serving academic, governmental, pharmaceutical, biotechnology, and industrial customers. In April 2025, Bruker announced a majority investment in RECIPE Chemicals + Instruments GmbH, a Munich-based provider of clinical diagnostic assays, enhancing its small molecule diagnostics capabilities through integration of RECIPE's ClinMASS kits for EVOQ liquid chromatography triple-quadrupole mass spectrometers and upcoming high-throughput ClinDART kits for chromatography-free workflows on EVOQ-DART systems. Earlier, in 2024, the company acquired Dynamic Biosensors GmbH to strengthen its biosensor portfolio for molecular interaction analysis, complementing high-performance surface plasmon resonance systems like SPR #64 'Triceratops' for pharmaceutical and biotechnology drug discovery. Bruker also secured approximately $10 million in federally funded NMR system orders in October 2025 from institutions including the New York Structural Biology Center, University of Delaware, and Northwestern University, while initiating a major cost savings program targeting $100-120 million in annual reductions by fiscal 2026 amid market pressures.

Company News

Company News APIChatGPT

  • seekingalpha.com

    Bruker Corporation (BRKR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

  • gurufocus.com

    Bruker Corporation to Present at Upcoming Investor Conferences

  • businesswire.com

    Bruker Corporation to Present at Upcoming Investor Conferences

  • gurufocus.com

    BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion

  • businesswire.com

    BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion

  • zacks.com

    Why Is Bruker (BRKR) Up 12.5% Since Last Earnings Report?

  • defenseworld.net

    Deutsche Bank AG Invests $1.44 Million in Bruker Corporation $BRKR

  • defenseworld.net

    745,079 Shares in Bruker Corporation $BRKR Purchased by Bank of New York Mellon Corp

  • defenseworld.net

    Handelsbanken Fonder AB Acquires 18,165 Shares of Bruker Corporation $BRKR

  • defenseworld.net

    Bruker Corporation $BRKR Shares Sold by Bank of America Corp DE

  • businesswire.com

    Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

  • gurufocus.com

    Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

  • businesswire.com

    Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

  • seekingalpha.com

    Bruker Corporation (BRKR) Q2 2026 Earnings Call Transcript

  • schaeffersresearch.com

    Dow, S&P 500 Climb to Fresh Record Highs

  • zacks.com

    Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

  • marketbeat.com

    Bruker Q2 Earnings Call Highlights

  • zacks.com

    Bruker (BRKR) Q2 Earnings Beat Estimates

  • gurufocus.com

    Bruker Reports Second Quarter 2026 Financial Results

  • businesswire.com

    Bruker Reports Second Quarter 2026 Financial Results